<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: The thrombin mutant W215A/E217A (WE thrombin) has greatly reduced procoagulant activity, but it activates protein C in the presence of thrombomodulin and inhibits binding of platelet <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> Ib to <z:e sem="disease" ids="C0042974" disease_type="Disease or Syndrome" abbrv="">von Willebrand</z:e> factor and collagen under flow conditions </plain></SENT>
<SENT sid="1" pm="."><plain>Both thrombomodulin-dependent protein C activation and inhibition of platelet <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> could contribute to the antithrombotic activity of WE thrombin </plain></SENT>
<SENT sid="2" pm="."><plain>MATERIALS AND METHODS: To assess the role of thrombomodulin, we administered WE thrombin to thrombomodulin-deficient (TM(Pro/Pro)) mice and measured the time to occlusive <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation in the carotid artery after photochemical injury of the endothelium </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS AND CONCLUSIONS: Doses of WE thrombin ≥10μg/kg prolonged the <z:mp ids='MP_0005048'>thrombosis</z:mp> time of <z:mp ids='MP_0002169'>wild-type</z:mp> mice (&gt;1.6-fold), while doses ≥100μg/kg only slightly prolonged the <z:mp ids='MP_0005048'>thrombosis</z:mp> time of TM(Pro/Pro) mice </plain></SENT>
<SENT sid="4" pm="."><plain>We conclude that thrombomodulin plays a predominate role in mediating the antithrombotic effect of WE thrombin in the arterial circulation of mice after endothelial injury </plain></SENT>
<SENT sid="5" pm="."><plain>Thrombomodulin-independent effects may occur only when high doses of WE thrombin are administered </plain></SENT>
</text></document>